Literature DB >> 18463036

Serum uric acid levels and risk of metabolic syndrome in healthy adults.

Pantea Ebrahimpour1, Hossein Fakhrzadeh, Ramin Heshmat, Fatemeh Bandarian, Bagher Larijani.   

Abstract

OBJECTIVE: To investigate the relationship between hyperuricemia and metabolic syndrome in a population of healthy subjects.
METHODS: We studied 1,573 healthy adults (25 to 64 years old) in the population laboratory of the Tehran University of Medical Sciences. The study was designed according to the World Health Organization MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) project with use of the National Cholesterol Education Program Adult Treatment Panel III criteria for metabolic syndrome.
RESULTS: The crude prevalence of the metabolic syndrome was 29.9% (age-adjusted, 27.5%). The rate of metabolic syndrome significantly increased in higher quartiles of serum uric acid in both sexes but especially in women (P<.0001 versus P = .026). The bivariate correlation was significant between uric acid levels and age, total serum cholesterol, high-density lipoprotein cholesterol, triglycerides, body mass index, waist and hip circumferences, waist-to-hip ratio, and systolic and diastolic blood pressures; however, there was not a significant correlation between serum uric acid concentrations and fasting plasma glucose.
CONCLUSION: These data indicate that an independent relationship exists between hyperuricemia and the metabolic syndrome. Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity. Early detection of hyperuricemia seems to be essential for prevention of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463036     DOI: 10.4158/EP.14.3.298

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  14 in total

1.  The Power of Serum Uric Acid in Predicting Metabolic Syndrome Diminishes With Age in an Elderly Chinese Population.

Authors:  J-H Chen; C-H Hsieh; J-S Liu; T-J Chuang; H-W Chang; C-L Huang; P-F Li; D Pei; Y-L Chen
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Serum uric acid in relation with the metabolic syndrome components and adiponectin levels in Lebanese University students.

Authors:  R Chedid; F Zoghbi; G Halaby; M-H Gannagé-Yared
Journal:  J Endocrinol Invest       Date:  2010-11-16       Impact factor: 4.256

3.  Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006.

Authors:  Mark D DeBoer; Matthew J Gurka
Journal:  Metab Syndr Relat Disord       Date:  2010-08       Impact factor: 1.894

4.  The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol.

Authors:  Jun Saito; Yoko Matsuzawa; Hiroko Ito; Masao Omura; Yuzuru Ito; Koichiro Yoshimura; Yuki Yajima; Tomoshige Kino; Tetsuo Nishikawa
Journal:  Endocr Res       Date:  2010       Impact factor: 1.720

5.  The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan.

Authors:  Jianmin Yang; Zhendong Liu; Cheng Zhang; Yingxin Zhao; Shangwen Sun; Shujian Wang; Yuxia Zhao; Yun Zhang; Jifu Li; Fanghong Lu
Journal:  Rheumatol Int       Date:  2012-12-15       Impact factor: 2.631

6.  Uric acid is an independent predictor of arterial stiffness in hypertensive patients.

Authors:  Wei-Chuan Tsai; Yao-Yi Huang; Chih-Chan Lin; Wei-Ting Li; Cheng-Han Lee; Ju-Yi Chen; Jyh-Hong Chen
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

7.  Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.

Authors:  Olha Hurba; Andrea Mancikova; Vladimir Krylov; Marketa Pavlikova; Karel Pavelka; Blanka Stibůrková
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial.

Authors:  Charlotte Andersson; Peter Weeke; Bente Brendorp; Lars Køber; Emil L Fosbøl; Arya M Sharma; Nick Finer; Ian D Caterson; Richard A Rode; Philip T James; Christian Torp-Pedersen
Journal:  Nutr Metab (Lond)       Date:  2009-10-14       Impact factor: 4.169

9.  Alkalizer administration improves renal function in hyperuricemia associated with obesity.

Authors:  Jun Saito; Yoko Matsuzawa; Hiroko Ito; Masao Omura; Tomoshige Kino; Tetsuo Nishikawa
Journal:  Jpn Clin Med       Date:  2013-02-03

10.  The association of serum gamma-glutamyl transpeptidase level and other laboratory parameters with blood pressure in hypertensive patients under ambulatory blood pressure monitoring.

Authors:  Adile Ortakoyluoglu; Betul Boz; Oguzhan Sıtkı Dizdar; Deniz Avcı; Ali Cetinkaya; Osman Baspınar
Journal:  Ther Clin Risk Manag       Date:  2016-09-07       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.